Researchers screened patients for mixed strain pathogen infections as part of a clinical trial and found that “at least 1/3 of patients are colonized by multiple Pseudomonas strains, and that resistance evolves rapidly in these patients due to selection for pre-existing resistant strains.”
They suggest additional investigation to fully understand this link but suggest that taking measurements on the diversity of a pathogen population could allow experts to “more accurately predict the likelihood of treatment failure at the level of individual patients,” the study authors wrote.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.